In partnership with Seagen, Sanofi will design, develop and commercialize ADCs for three cancer targets using Sanofis proprietary monoclonal antibody technology and Seagens proprietary ADC technology
The agency said compounding pharmacies had to phase out manufacturing the copycat versions over the spring
instead, new plants should be built with modularity for evolving processes (e.g
By 2035, oral formulations will expand the overall market by targeting new, hitherto unaddressed patient populations rather than taking significant share from existing injectables
Several studies recommend splitting supplemental L-carnitine intake into two or three doses, says Rickelle Tallent, RDN, LD, owner of Tallent Nutrition & Wellness in Las Vegas, Nevada